BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16210038)

  • 21. Properties of myelofibrosis-derived fibroblasts.
    Castro-Malaspina H; Jhanwar SC
    Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
    Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
    Best Pract Res Clin Haematol; 2006; 19(3):495-517. PubMed ID: 16781486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003.
    Mesa RA
    Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of an expanded circulating hematopoietic progenitor cell pool associated with bone marrow fibrosis for the support of autologous transplantation in IgD multiple myeloma.
    de la Serna J; Bornstein R; Lahuerta-Palacios JJ
    Bone Marrow Transplant; 1997 May; 19(10):1033-6. PubMed ID: 9169649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide for the treatment of idiopathic myelofibrosis.
    Strupp C; Germing U; Scherer A; Kündgen A; Mödder U; Gattermann N; Haas R
    Eur J Haematol; 2004 Jan; 72(1):52-7. PubMed ID: 14962263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
    Thiele J; Kvasnicka HM; Boeltken B; Zankovich R; Diehl V; Fischer R
    Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic stem cell transplantation for myelofibrosis.
    van Besien K; Deeg HJ
    Semin Oncol; 2005 Aug; 32(4):414-21. PubMed ID: 16202687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic myelofibrosis: a retrospective study of 103 patients.
    Anger B; Seidler R; Haug U; Popp C; Heimpel H
    Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
    Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
    Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An etiologic model proposing that sporadic adult-onset carcinoma is extramedullary hematopoiesis.
    Schiel KA
    Med Hypotheses; 2006; 67(1):93-109. PubMed ID: 16540257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopathologic findings in chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Semin Oncol; 2005 Aug; 32(4):380-94. PubMed ID: 16202684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis.
    Bock O; Neusch M; Büsche G; Mengel M; Kreipe H
    Eur J Haematol; 2004 Apr; 72(4):239-44. PubMed ID: 15089760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and old treatment modalities in primary myelofibrosis.
    Cervantes F; Mesa R; Barosi G
    Cancer J; 2007; 13(6):377-83. PubMed ID: 18032975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approaches in the treatment of myelofibrosis.
    Hennessy BT; Thomas DA; Giles FJ; Kantarjian H; Verstovsek S
    Cancer; 2005 Jan; 103(1):32-43. PubMed ID: 15565565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelofibrosis with myeloid metaplasia.
    Barosi G
    Hematol Oncol Clin North Am; 2003 Oct; 17(5):1211-26. PubMed ID: 14560783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.